Press release
Pressurized Metered Dose Inhalers Market Sees Momentum with COPD and Asthma Prevalence | AstraZeneca PLC, GlaxoSmithKline Inc., Merck & Co., Inc.
"The Global Pressurized Metered Dose Inhalers Market reached US$ 5,961.40 million in 2024 and is expected to reach US$ 9,212.15 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033." As per DataM intelligence research reportMarket growth opportunities(2025-2031):
The market is set to grow substantially due to the rising burden of respiratory illnesses like asthma and COPD across aging and urban populations. Increased adoption of pMDIs thanks to their portability and rapid therapeutic action is fueling demand. Emerging regions, particularly in Asia-Pacific, present robust growth potential owing to expanding healthcare access and rising awareness. Technological innovations such as smart inhalers and eco-friendly propellants are creating new market segments. These factors collectively establish a favorable environment for expansion and clinical acceptance.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/pressurized-metered-dose-inhalers-market?sp
Pressurized Metered Dose Inhalers Market: Recent Industry Developments
✅ In July 2025, AstraZeneca launched its new eco-friendly pMDI using HFO-1234ze propellant in Europe.It reduces carbon emissions by over 90% compared to traditional inhalers without compromising drug delivery.The launch aligns with the company's commitment to sustainable respiratory care.
✅ In June 2025, Teva Pharmaceuticals received FDA approval for a generic fluticasone-salmeterol pMDI.This affordable alternative aims to improve accessibility to combination asthma therapy in the U.S. market.Distribution began in early July through retail and hospital channels.
✅ In May 2025, Vectura partnered with Chiesi Group to co-develop a next-gen digital pMDI platform.The device will feature integrated dose tracking, usage alerts, and Bluetooth connectivity.Clinical trials are expected to begin in Q4 2025 targeting asthma and COPD patients.
✅ In April 2025, Glenmark Pharmaceuticals launched its Niveoli pMDI with a novel formulation for faster lung deposition.The new technology enhances bronchodilation in acute asthma episodes.The product is now available in key APAC and European markets.
✅ In March 2025, Catalent invested $60 million in expanding its U.K.-based pMDI filling and packaging facility.This expansion supports growing demand from branded and generic respiratory drug developers.It also enhances production of low-GWP (Global Warming Potential) inhalers.
Pressurized Metered Dose Inhalers Market: Drivers
The market is driven by the growing prevalence of respiratory diseases such as asthma and COPD, especially in densely populated urban areas and among older adults. The convenience, portability, and fast action of pressurized metered-dose inhalers make them a preferred drug delivery option. Rising awareness and diagnosis rates, along with improved access to healthcare infrastructure in emerging economies, support widespread adoption. Regulatory initiatives promoting greener inhaler technologies also contribute to industry momentum. Additionally, technological advancements are driving innovation in both functionality and environmental safety.
Pressurized Metered Dose Inhalers Market: Technological Advancements
✦ Development of low-global warming potential (GWP) propellants such as HFA‐152a and HFO‐1234ze significantly reduce environmental impact, supporting regulatory compliance and sustainability initiatives.
✦ Smart inhalers with sensors, Bluetooth connectivity, and dose tracking are improving treatment adherence and enabling remote monitoring by healthcare professionals.
✦ Introduction of breath-actuated and combination-therapy inhalers enhances accuracy and ease of use, especially for pediatric and elderly populations.
✦ AI-powered inhaler systems are enabling personalized therapy adjustments and early detection of respiratory condition exacerbations through real-time data analysis.
✦ Use of recyclable and biodegradable materials in inhaler manufacturing supports the shift toward environmentally sustainable production and lifecycle management.
Strategic Players Driving the Pressurized Metered Dose Inhalers Market Forward:
AstraZeneca PLC, GlaxoSmithKline Inc., Merck & Co., Inc., Lupin, Glenmark Pharmaceuticals Ltd., Cognita Labs, LLC, Bespak Limited, Healthgate PVT. LTD., Nemera, Getz Pharma (Pvt.) Ltd. and among others.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pressurized-metered-dose-inhalers-market?sp
Segment Covered in the Pressurized Metered Dose Inhalers Market:
➥ By Type: Single Dose Pressurized Metered Dose Inhalers, Multi Dose Pressurized Metered Dose Inhalers
➥ By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Emphysema, Others
➥ By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Why Purchase the Report for Pressurized Metered Dose Inhalers Market?:
➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pressurized-metered-dose-inhalers-market?sp
Regional Analysis for Pressurized Metered Dose Inhalers Market:
North America leads the global market due to high disease prevalence, advanced healthcare infrastructure, and early adoption of new inhaler technologies. Europe follows closely, emphasizing sustainable inhaler propellants and strict regulatory standards. Asia-Pacific is projected to witness the fastest growth, supported by rising pollution-related respiratory conditions, expanding healthcare facilities, and increasing public health initiatives in developing nations.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pressurized Metered Dose Inhalers Market Sees Momentum with COPD and Asthma Prevalence | AstraZeneca PLC, GlaxoSmithKline Inc., Merck & Co., Inc. here
News-ID: 4136978 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Hybrid Energy Storage Market Projected to Expand at 6.89% CAGR, Re …
The global Hybrid Energy Storage Market reached US$ 16.56 billion in 2024 and is projected to reach US$ 28.22 billion by 2032, growing at a CAGR of 6.89% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, Tesla launched its next-generation Megapack 2.0 with integrated lithium-ion and flow battery technology for grid-scale applications.
✅ In August 2025, The Department of Energy announced $2.1…

United States Pyelonephritis Treatment Market Projected to Expand at 5.8% CAGR, …
The global Pyelonephritis Treatment Market reached US$ 1,014.39 million in 2024 and is projected to reach US$ 1,682.83 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The FDA approved a new extended-release antibiotic formulation for complicated urinary tract infections, including pyelonephritis.
✅ In August 2025, CDC updated treatment guidelines for antibiotic-resistant pyelonephritis cases,…

United States Uterine Cancer Treatment Market to Reach USD 39.0 Billion by 2033, …
The global Uterine Cancer Treatment Market reached US$ 23,633.46 Million in 2024 and is projected to reach US$ 39,007.22 Million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The FDA granted breakthrough therapy designation for Novartis' new targeted combination therapy for advanced endometrial cancer following promising Phase III trial results.
✅ In August 2025,…

United States Medical Device Contract Manufacturing Market 2025 | Growth Drivers …
Market Size and Growth
The global medical device contract manufacturing market size reached US$ 76.43 Billion in 2024 from US$ 69.54 Billion in 2023 and is expected to reach US$ 190.88 Billion by 2033, growing at a CAGR of 10.9% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In August 2025, Flex Ltd. expanded its medical device outsourcing services for U.S. clients, focusing on design, prototyping, and full-scale manufacturing.
✅…
More Releases for Dose
North America Leads the Surge in Metered-Dose Inhalers Market Adoption | Metered …
The Global Metered-Dose inhalers Market reached US$ 16.6 billion in 2023 and is expected to reach US$ 24.18 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.
The Metered-Dose Inhalers (MDI) Market focuses on drug delivery devices used in managing respiratory disorders like asthma and COPD. MDIs provide precise, portable, and fast-acting medication administration. The market is expanding due to growing respiratory disease incidence and environmental…
Global Radiation Dose Management Platform Market Size by Application, Type, and …
According to Market Research Intellect, the global Radiation Dose Management Platform market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The Radiation Dose Management Platform Market is witnessing notable growth due to increasing awareness around patient…
Radiation Dose Management Market Report 2024 - Radiation Dose Management Market …
"The Business Research Company recently released a comprehensive report on the Global Radiation Dose Management Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Radiation Dose Management Market Report by Product & Service (Radiation Dose Man …
Global Radiation Dose Management Market
The global radiation dose management market is projected to experience significant growth, expanding from US$330.87 million in 2023 to US$1,004.39 million by 2032. This represents a compound annual growth rate (CAGR) of 13.13% from 2024 to 2032, driven by factors such as the increasing prevalence of diseases like cancer, rapid growth in the healthcare sector, and investments in research and development.
Orthopedic Prosthetics Market Table of Content…
Radiation Dose Management Market - Radiation Dose Tracking Excellence: Elevating …
Newark, New Castle, USA: The "Radiation Dose Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Radiation Dose Management Market: https://www.growthplusreports.com/report/radiation-dose-management-market/8706
This latest report researches the industry structure,…
KOPI Deva - Single Dose Coffee Grinder
KOPI Deva
Introducing the KOPI Deva: a single dose grinder for home baristas that is suitable for any brew method. The Deva’s specially designed short grind path drastically reduces retention, and gives you the freshest possible coffee, utilising every bean.
The stepless grind adjustment lets you finely tune your flavours. Sitting at the forefront of espresso experimentation, the Deva also allows you to change the speed of the burrs (200-1000…